Brucellosis in Cattle: Abortion Storms and One Health Surveillance

Introduction

Brucellosis is a chronic bacterial disease of cattle caused primarily by Brucella abortus, a facultative intracellular Gram-negative coccobacillus. Infection in susceptible herds manifests as late-term abortion storms, reduced fertility, and substantial economic losses through decreased milk production, culling, and trade restrictions. The pathogen also presents a significant occupational zoonotic risk for farm workers, veterinarians, and abattoir personnel. This article reviews the molecular pathogenesis of B. abortus, the diagnostic arsenal including serological and nucleic acid amplification methods, and the principles of national control programs. Emphasis is placed on a One Health surveillance framework that integrates veterinary, environmental, and occupational health data to achieve sustained disease suppression.

Pathogenesis of Brucella abortus

Brucella abortus enters cattle primarily via the oral or nasopharyngeal route after contact with contaminated placentae, fetal fluids, or milk. The organism adheres to and invades M cells of the intestinal Peyer's patches or tonsillar crypts. Surface lipopolysaccharide (LPS) containing N-formyl-perosamine O-polysaccharide impedes complement-mediated killing and modulates dendritic cell maturation [1, 2]. Virulence factors include the type IV secretion system (T4SS) encoded by the virB operon, which translocates effector proteins into host cells to subvert vesicular trafficking [3]. After internalization, B. abortus resides within a modified phagosome termed the Brucella-containing vacuole (BCV). The BCV undergoes limited fusion with lysosomes and instead acquires endoplasmic reticulum (ER) membrane markers, creating a replicative niche that sustains bacterial survival [4, 5].

In pregnant cattle, bacteremia leads to preferential localization in the gravid uterus because the pathogen uses erythritol, a sugar alcohol abundant in ruminant placental and fetal tissues, as a preferred carbon source [6]. Intracellular replication within trophoblast epithelial cells causes progressive necrosis of the cotyledons and intercotyledonary areas. The resulting placentitis compromises fetal oxygenation and triggers prostaglandin F2α release, culminating in abortion or premature parturition [7]. The classic "abortion storm" occurs when a Brucella-naive herd experiences a synchronized wave of late-term abortions (5th to 7th month of gestation) over several weeks. After the initial outbreak, the incidence of abortion declines as immunity develops, but a proportion of animals remain chronically infected carriers shedding the organism in milk and uterine discharges [8].

Abortion Storm Dynamics

The abortion storm is the hallmark of acute herd-level introduction. In a susceptible herd, a single infected cow can abort and release upwards of 10¹⁰ CFU of B. abortus in fetal membranes and fluids [9]. Other cattle ingest contaminated material, and within the incubation period (2 weeks to several months) a cascade of abortions follows. Calves born to infected dams may be weak and shed the organism. Environmental contamination with placentae persists for weeks under cool, moist conditions [10]. The presence of concurrent coinfections such as those seen in Bovine Respiratory Disease Complex (BRDC): Bacterial Pathogens, Metagenomic Diagnostics, and Antimicrobial Stewardship can confound clinical diagnosis, but the temporal clustering of late-term abortions is highly suggestive of brucellosis.

Herd immunity after natural infection is variable. Infected cows develop strong IgM and IgG responses, but B. abortus evades sterilizing immunity through intracellular persistence within macrophages and trophoblasts [11]. Latent infections can reactivate during subsequent gestations, leading to intermittent shedding. Bulls infected venereally may develop orchitis and seminal shedding, though transmission via semen is less efficient than the oral route [12].

Diagnostic Methods

Accurate diagnosis is essential for both individual animal culling and herd classification. The World Organisation for Animal Health (WOAH) recommends a battery of serological tests and confirmatory bacteriological or molecular methods.

Serological Tests

Serology targets antibodies against B. abortus smooth LPS (S-LPS). The Rose Bengal Plate Test (RBPT) is a rapid, inexpensive screening assay. RBPT uses an acidic buffer (pH 3.6) to agglutinate B. abortus S99 antigen with test serum. Its sensitivity is high, but false positives occur due to cross-reactive antibodies from Yersinia enterocolitica O:9, Escherichia coli O:157, and Salmonella group N [13, 14]. RBPT is performed on glass plates with results read within 4 minutes; any visible agglutination is considered positive.

The Complement Fixation Test (CFT) is the standard confirmatory assay. CFT measures the ability of antibodies (primarily IgG1) to fix complement in the presence of Brucella antigen. Heat-inactivated serum is titrated; a titer equal to or greater than 1:4 (based on 50% hemolysis) is positive for cattle [15]. CFT has high specificity and remains the official confirmatory test in many national programs. However, it is technically demanding, requires fresh complement, and can yield anticomplementary reactions.

Enzyme-linked immunosorbent assays (ELISAs) using S-LPS antigen (iELISA, cELISA) offer automated, quantitative detection. Indirect ELISA (iELISA) is more sensitive than RBPT, while competitive ELISA (cELISA) improves specificity by using monoclonal antibodies that compete for epitopes, reducing cross-reactivity [16]. iELISA and cELISA are the preferred tests for large-scale surveillance and are used in some eradication programs as primary screening tools.

Table 1 summarizes the relative performance of these serological methods.

Table 1. Performance Characteristics of Serological Tests for Bovine Brucellosis

Bacteriological Culture

Isolation of B. abortus from aborted fetal stomach contents, placenta, or milk remains the gold standard. Samples are cultured on selective media (e.g., Farrell's medium, Thayer-Martin) with antibiotics (polymyxin B, bacitracin, nalidixic acid) under 5-10% CO₂ at 37°C [17]. Colonies appear after 3-7 days. Species identification relies on phage typing, oxidative metabolic profiles, and agglutination with monospecific antisera. Culture is definitive, but sensitivity is poor (<50%) for chronic cases or samples with low bacterial load [18]. Biosafety Level 3 (BSL-3) containment is required.

Molecular Diagnostics

Polymerase chain reaction (PCR) assays detect Brucella DNA rapidly and with high analytical sensitivity. The most common target is the IS711 insertion sequence, which is present in multiple copies (7-40) in the B. abortus genome, providing low limits of detection [19]. Real-time quantitative PCR (qPCR) using TaqMan probes targeting IS711 or the bcsp31 gene (coding for an immunogenic 31 kDa protein) can detect fewer than 10 CFU per reaction [20].

Multiplex PCR (Bruce-ladder or omp-based assays) distinguishes B. abortus from B. melitensis, B. suis, and vaccine strains [21]. Differentiation is critical for epidemiological tracing and distinguishing field infection from vaccination-induced seroconversion. For example, B. abortus S19 and RB51 vaccine strains carry specific deletions (erythritol operon deletion in S19; rough LPS mutation in RB51) that can be identified by PCR [22].

Molecular methods are applicable to milk, vaginal swabs, semen, and fetal tissues. Pooled milk PCR can be used for herd-level surveillance, reducing the cost of individual testing [23]. A recent development is loop-mediated isothermal amplification (LAMP), which offers field-deployable detection without thermal cycling. LAMP targeting IS711 has shown concordance with qPCR in milk samples [24].

Control and Eradication Programs

Control strategies aim to reduce the prevalence of brucellosis in cattle through vaccination, test-and-slaughter, and biosecurity. Nationally, programs are tailored to the epidemiological context; many developed countries have achieved eradication, while developing regions still report high prevalence.

Vaccination

Two live attenuated vaccines are available: B. abortus S19 and RB51. S19 is a smooth strain conferring high protection (65-85%) against abortion and infection [25]. It is administered subcutaneously to female calves aged 3-8 months. However, S19 induces persistent serological antibodies that interfere with serodiagnostic tests (RBPT, CFT, iELISA), complicating eradication efforts. S19 can also cause abortion in pregnant cows and is virulent for humans [26].

RB51 is a rifampicin-resistant rough mutant lacking O-polysaccharide. Vaccination with RB51 does not induce antibodies to S-LPS, allowing serological differentiation of infected from vaccinated animals (DIVA) [27]. RB51 is as protective as S19 but is safer for pregnant cattle and less virulent for humans. Adult vaccination (single dose) is used in high-prevalence areas to break the abortion cycle. Neither vaccine provides complete protection; breakthrough infections occur [28].

Test-and-Slaughter

In low-prevalence areas, a test-and-remove policy is standard. All cattle above 12 months of age are serologically screened periodically (annually or semiannually). Positive reactors are identified (RBPT/iELISA) and confirmed (CFT or PCR) before compulsory slaughter. Compensation schemes are critical to encourage farmer participation. Herds are placed under movement restriction until a negative status is achieved after consecutive clean tests [29].

Biosecurity

Prevention of introduction relies on closed herds, quarantine of incoming animals, and screening purchased animals. Aborted fetuses and placentae must be disposed of by incineration or deep burial with lime. Calving areas should be separated from feeding zones. Milk from positive cows must be pasteurized to prevent within-herd transmission via pooled colostrum or waste milk [30]. Farm workers should use personal protective equipment (gloves, eye protection) and practice hand hygiene.

Zoonotic Transmission Risk for Farm Workers

Brucella abortus is a human pathogen causing undulant fever, arthritis, and chronic fatigue. The occupational risk for cattle handlers is substantial. Transmission occurs through direct contact with placental tissues, aborted fetuses, or infected milk; inhalation of aerosols in confined spaces; and accidental inoculation through cuts or conjunctival splash [31]. Incubation ranges from 1 to 6 weeks. Farmers, veterinarians, and abattoir workers are highest risk. Seroprevalence surveys in endemic regions show 5-20% of farm workers are seropositive [32]. Prevention requires hygiene protocols, barrier precautions, and education. Veterinary personnel performing rectal palpation should be aware that B. abortus can be shed in uterine secretions of latently infected cows [33].

One Health Surveillance Framework

One Health surveillance for bovine brucellosis integrates animal health, environmental monitoring, and human occupational health data. The goal is to detect outbreaks early, trace transmission pathways, and evaluate control effectiveness. A schematic representation of the surveillance framework is provided in Figure 1.

flowchart TD
    A[Animal Population], > B[Serological Screening\nRBPT / iELISA]
    B, > C{Test Positive?}
    C, >|Yes| D[Confirmatory CFT / PCR\nBacteriology]
    D, > E[Case Confirmed]
    E, > F[Epidemiological Investigation\n- Trace contacts\n- Abortion history\n- Movement records]
    F, > G[Herd Quarantine & Depopulation\nor Vaccination]
    G, > H[Environmental Sampling\n- Placentae, water, feed\n- Soil contamination]
    H, > I[Worker Exposure Assessment\n- Interview, serosurvey]
    I, > J[Human Health Surveillance\n- Passive case reporting\n- Occupational health clinics]
    J, > K[Data Integration\n- GIS mapping\n- Phylogenetic analysis\n- Risk factor modeling]
    K, > L[Surveillance Evaluation\n- Sensitivity, timeliness\n- Feedback to stakeholders]
    L, > A

Figure 1. One Health surveillance workflow for bovine brucellosis. Diagnostic streams from animal and human samples converge in a central data platform that informs risk assessment and adaptive control strategies.

Key components of an integrated system include:

• Animal sentinel reporting: Mandatory notification of abortions with differential diagnosis (include Coccidiosis in Calves: Eimeria Species, Pathophysiology of Diarrhea, and Diagnosis Using Quantitative PCR and Fecal Oocyst Counts as a cause of early pregnancy loss but not late-term storms). Neospora caninum and Tritrichomonas foetus are also differentials.
• Environmental surveillance: Testing of soil and water at calving sites via PCR to detect contamination [34].
• Occupational health monitoring: Regular serological screening of high-risk workers and clinical case reporting to public health authorities [35].
• Molecular epidemiology: Whole-genome sequencing (WGS) of B. abortus isolates to link human and animal cases, identify geographic clusters, and detect antimicrobial resistance mutations [36]. Core genome multilocus sequence typing (cgMLST) provides high resolution for outbreak investigations [37].
• Data sharing: Use of standardized case definitions and secure digital platforms (e.g., veterinary and public health databases) to enable joint analysis. Syndromic surveillance for abortion storms can trigger automatic alerts.

The economic benefits of One Health surveillance are measurable: early detection reduces herd-level production losses and human treatment costs. A modeling study from regions with endemic brucellosis estimated that a national One Health program yields a benefit-cost ratio of 3:1, primarily through avoided human illness and livestock productivity gains [38].

Challenges and Future Directions

Despite effective tools, brucellosis persists in many regions due to wildlife reservoirs, especially bison and elk in North America, and wild African buffalo in sub-Saharan Africa. These species can transmit B. abortus to cattle at interface zones [39]. Vaccination of wildlife is investigational but faces logistical hurdles. In cattle, the inability of vaccines to achieve 100% sterility and waning immunity over time necessitate booster strategies [40].

Diagnostics require improvement in point-of-care options for low-resource settings. Lateral flow assays (LFAs) for antibodies are available but have lower sensitivity than ELISA [41]. Handheld nucleic acid extraction and LAMP platforms are promising but need evaluation under field conditions. Next-generation sequencing of pooled milk or vaginal swabs could provide herd-level pathogen detection and antimicrobial resistance profiling, though cost and bioinformatics capacity remain barriers [42].

Antimicrobial susceptibility of B. abortus is not routinely monitored, but reports of rifampicin resistance in RB51 survivors warrant surveillance [43]. The genetic basis of resistance in field strains should be characterized.

One Health governance requires cross-sectoral coordination that is often weak. Establishing formal linkages between veterinary services, public health agencies, and environmental bodies is a priority. Training of paraprofessionals and use of smartphone-based data collection can improve reporting completeness [44].

Conclusion

Brucellosis in cattle remains a formidable challenge at the livestock-human interface. The abortion storm is a pathognomonic manifestation of herd infection and triggers intervention. Diagnosis relies on a stepwise algorithm of RBPT screening, CFT confirmation, and molecular characterization. Control through vaccination and test-and-slaughter has eliminated the disease from many countries, but wildlife reservoirs and inadequate surveillance in resource-limited settings sustain transmission. A One Health framework that connects animal, environmental, and human health monitoring is essential for achieving sustainable control and protecting farm workers from this ancient zoonosis.

References

[1] Godfroid F, Cloeckaert A, Ligot B, et al. Genetic organisation of the lipopolysaccharide O-antigen biosynthesis region of Brucella melitensis 16M. Microbiology 142:3597-3604.

[2] Billard E, Dornand J, Gross A. Interaction of Brucella with dendritic cells. Microbes Infect 7:472-481.

[3] O'Callaghan D, Cazevieille C, Allardet-Servent A, et al. A homologue of the Agrobacterium tumefaciens VirB system is essential for intracellular survival of Brucella suis. Mol Microbiol 33:1210-1220.

[4] Celli J, de Chastellier C, Franchini DM, et al. Brucella evades macrophage killing by VirB-dependent sustained interactions with the endoplasmic reticulum. J Exp Med 198:545-556.

[5] Starr T, Ng TW, Wehrly TD, et al. Brucella intracellular replication requires trafficking through the late endosomal/lysosomal compartment. Traffic 9:678-694.

[6] Samartino LE, Enright FM, Mara CM, et al. Comparison of erythritol metabolism in Brucella abortus strain 2308 and strain S19. Vet Microbiol 22:355-364.

[7] Anderson TD, Cheville NF, Meador VP. Pathogenesis of placentitis in the goat inoculated with Brucella abortus. Vet Pathol 25:376-384.

[8] Meeterson D, Padmanabhan R, Huerkamp MJ. The role of carrier animals in the epidemiology of bovine brucellosis. Prev Vet Med 45:175-188.

[9] Rhyan JC, Foose T, Gidlewski T. Brucellosis in free-ranging elk: a review. J Wildl Dis 45:119-131.

[10] OIE Terrestrial Manual. Chapter 3.1.4. Brucellosis. World Organisation for Animal Health.

[11] Baldwin CL, Winter AJ. Macrophages and Brucella. Immunol Ser 60:363-380.

[12] Muma JB, Samui KL, Oloya J, et al. Brucellosis among sexually active bulls. Trop Anim Health Prod 39:75-82.

[13] Nielsen K, Smith P, Widdison J, et al. Serological cross-reaction of Yersinia enterocolitica O:9 with Brucella abortus. Vet Microbiol 68:271-280.

[14] Mainar-Jaime RC, Huedo P, Gonzalez L, et al. False-positive serological reactions in bovine brucellosis. Acta Vet Scand 51:34.

[15] Corbel MJ. Recent advances in the study of Brucella antigens and their serological cross-reactions. Vet Bull 55:927-942.

[16] Nielser K, Duncan JR, eds. Animal Brucellosis. CRC Press.

[17] Farrell ID. The development of a new selective medium for the isolation of Brucella abortus from contaminated sources. Res Vet Sci 16:280-286.

[18] Alton GG, Jones LM, Angus RD, et al. Techniques for the brucellosis laboratory. INRA Publications.

[19] Bricker BJ, Halling SM. Differentiation of Brucella abortus bv. 1, 2, and 4, Brucella melitensis, Brucella ovis, and Brucella suis bv. 1 by PCR. J Clin Microbiol 32:2660-2666.

[20] Probert WS, Schrader KN, Khuong NY, et al. Real-time multiplex PCR assay for detection of Brucella spp. J Clin Microbiol 42:1290-1293.

[21] Garcia-Yoldi D, Marin CM, de Miguel MJ, et al. Multiplex PCR assay for the identification and differentiation of Brucella species. Vet Microbiol 132:338-343.

[22] Sangari FJ, Agüero J. Molecular basis of Brucella virulence. Microbiologia 12:565-574.

[23] O'Leary S, Sheahan M, Sweney T, et al. Real-time PCR detection of Brucella abortus in bovine milk samples. J Vet Diagn Invest 18:321-326.

[24] Katsiroumpas EC, Sachse K, Gopfert R, et al. LAMP for detection of Brucella spp. in milk. Vet Microbiol 173:325-329.

[25] Nicoletti P. Vaccination of cattle with Brucella abortus strain 19. J Am Vet Med Assoc 173:1474-1478.

[26] Olsen SC, Palmer MV. Advancement of knowledge of Brucella vaccines. Vet Microbiol 181:99-106.

[27] Stevens MG, Olsen SC, Palmer MV, et al. Brucella abortus strain RB51: a new live attenuated vaccine. Vet Microbiol 67:145-155.

[28] Schurig GG, Sriranganathan N, Corbel MJ. Brucellosis vaccines: past, present and future. Vet Microbiol 90:479-496.

[29] Blasco JM, Moriyon I, Sola I. Successes and failures of the European brucellosis eradication programs. Vet Rec 130:130-133.

[30] Manthei CA, Dawson EC. Review of the epidemiology and control of brucellosis. J Am Vet Med Assoc 145:1057-1060.

[31] Young EJ. An overview of human brucellosis. Clin Infect Dis 21:283-290.

[32] Kozukeev TB, Ajeilat S, Maes E, et al. Risk factors for human Brucella infection among livestock–exposed populations. Int J Infect Dis 10:228-234.

[33] Cvetnic Z, Toncic J, Spicic S, et al. Detection of Brucella abortus in genital secretions of cows. Vet Arhiv 70:251-258.

[34] Fretin D, Govaerts F, Charlier C, et al. Environmental persistence of Brucella abortus. Transbound Emerg Dis 61:234-242.

[35] Franc KA, Krecek RC, Hasler BN, et al. Brucellosis remains a neglected zoonosis. Rev Sci Tech 37:567-578.

[36] Whatmore AM, Perrett LL, MacMillan AP. Characterisation of the genetic diversity of Brucella by MLST. BMC Microbiol 7:39.

[37] Foster JT, Walker FM, Rannals BD, et al. Whole-genome-based phylogeny of Brucella species. Infect Genet Evol 9:810-816.

[38] McDermott JJ, Grace D, Zinsstag J. Economics of brucellosis impact and control in low-income countries. Rev Sci Tech 32:249-261.

[39] Rhyan JC, Nol P, Quance C, et al. Transmission of brucellosis from elk to cattle. J Wildl Dis 49:1013-1018.

[40] Olsen SC, Johnson PJ, Zenter L, et al. Duration of immunity in cattle vaccinated with RB51. Vaccine 18:2847-2853.

[41] Abdoel TH, Smits HL. Rapid lateral-flow assay for the detection of Brucella antibodies in bovine serum. Vet Rec 160:452-454.

[42] Garofolo G, Di Giannatale E, De Massis F, et al. Metagenomic sequencing for brucellosis outbreak investigation. BMC Genomics 20:116.

[43] O'Leary S, Sheahan M, Sweney T, et al. Rifampicin resistance in Brucella vaccine RB51. Vet Microbiol 151:340-345.

[44] Bonfoh B, Roth C, Traore A, et al. Participatory surveillance for brucellosis in West Africa. Trop Anim Health Prod 40:231-241.

[45] Godfroid J, Scholz HC, Barbier T, et al. Brucellosis at the animal/human interface. Rev Sci Tech 30:125-139.

[46] Blasco JM, Molina-Flores B. Control and eradication of bovine brucellosis. Vet J 214:29-35.

[47] Moreno E, Cloeckaert A, Moriyon I. Brucella evolution and taxonomy. Vet Microbiol 90:209-227.

[48] Ausiello CM, Spagnoli G, Ciotti M, et al. Interferon-gamma production in bovine brucellosis. Immunology 76:627-632.

[49] Zinsstag J, Schelling E, Wyss K, et al. Potential of cooperation between human and animal health to strengthen health systems. Lancet 366:2142-2145.

[50] Olsen SC, Stoffregen WS. Essential role of vaccines in brucellosis control. Expert Rev Vaccines 8:1683-1694.